Bausch + Lomb Corporation announced the presentation of new scientific data and events taking place during the American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in Washington, D.C., April 10-13, 2026.
Forty-five presentations and posters will highlight the results of studies evaluating the company’s broad portfolio of products, including the ELIOS minimally-invasive glaucoma surgery (MIGS) system*, enVista Envy Full Visual Range and enVista Aspire intraocular lenses (IOLs), MIEBO (perfluorohexyloctane ophthalmic solution), ScoutPro point-of-care osmolarity testing device, Stellaris Elite Vision Enhancement System, TENEO Excimer Laser Platform and XIIDRA (lifitegrast ophthalmic solution) 5%.
*The ELIOS Procedure is in development and is not available for sale in the United States.
